StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CPRX

Catalyst Pharmaceuticals Inc

CPRX Nasdaq Pharmaceutical Preparations EDGAR ↗
$31.49

Key statistics

from XBRL data in SEC filings
Market cap
$3.85B
Revenue (TTM)
$597M
Net income (TTM)
$221M
EPS (TTM)
$1.73
P/E ratio
18.2
Dividend yield
Free cash flow
$209M
Cash
$756M
Total assets
$1.15B
Gross margin
52-week range
$19.05 – $32.56

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Completed an acquisition or disposition; Delisting notice or listing-rule failure; Modified rights of security holders; Change in control; Director or officer change; Amended charter or bylaws Jul 16, 2026 8-K Director or officer change; Shareholder vote results Jul 8, 2026 8-K Other events Jun 30, 2026 8-K Other events Jun 23, 2026 8-K Other events May 11, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Entered a material agreement; Amended charter or bylaws; Regulation FD disclosure; Other events May 7, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K/A Other events Mar 19, 2026 8-K Other events Mar 18, 2026 8-K Other events Feb 25, 2026 10-K Fiscal year ended 2025-12-31 Feb 25, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Other events Nov 5, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Other events Oct 1, 2025 8-K/A Aug 28, 2025 8-K Other events Aug 25, 2025 8-K Other events Aug 7, 2025 8-K Other events Aug 6, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Director or officer change Aug 4, 2025 8-K Other events Jun 2, 2025 8-K Director or officer change; Shareholder vote results May 23, 2025 8-K Other events May 7, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Other events Apr 9, 2025 8-K Other events Feb 26, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Director or officer change Jan 24, 2025 8-K Other events Jan 21, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Other events Jan 8, 2025 8-K Other events Nov 6, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Other events Sep 26, 2024 8-K Other events Aug 7, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Other events Jul 26, 2024 8-K Other events May 30, 2024